On September 1, 2025, Syndax Pharmaceuticals (NASDAQ: SNDX) disclosed granting inducement awards to acquire a total of 167,400 shares of common stock to 11 fresh hires under the 2023 Inducement Plan. The stock options will gradually vest across four years, with 25% of the shares becoming available after one year from the commencement date, and the rest vesting monthly in 1/48th increments over the following 36 months. The employees must maintain their service with Syndax to receive the shares on the specified dates.